Assessing ascertainment bias in atrial fibrillation across US minority groups

PLoS One. 2024 Apr 16;19(4):e0301991. doi: 10.1371/journal.pone.0301991. eCollection 2024.

Abstract

The aim of this study is to define atrial fibrillation (AF) prevalence and incidence rates across minority groups in the United States (US), to aid in diversity enrollment target setting for randomized controlled trials. In AF, US minority groups have lower clinically detected prevalence compared to the non-Hispanic or Latino White (NHW) population. We assess the impact of ascertainment bias on AF prevalence estimates. We analyzed data from adults in Optum's de-identified Clinformatics® Data Mart Database from 2017-2020 in a cohort study. Presence of AF at baseline was identified from inpatient and/or outpatient encounters claims using validated ICD-10-CM diagnosis algorithms. AF incidence and prevalence rates were determined both in the overall population, as well as in a population with a recent stroke event, where monitoring for AF is assumed. Differences in prevalence across cohorts were assessed to determine if ascertainment bias contributes to the variation in AF prevalence across US minority groups. The period prevalence was respectively 4.9%, 3.2%, 2.1% and 5.9% in the Black or African American, Asian, Hispanic or Latino, and NHW population. In patients with recent ischemic stroke, the proportion with AF was 32.2%, 24.3%, 25%, and 24.5%, respectively. The prevalence of AF among the stroke population was approximately 7 to 10 times higher than the prevalence among the overall population for the Asian and Hispanic or Latino population, compared to approximately 5 times higher for NHW patients. The relative AF prevalence difference of the Asian and Hispanic or Latino population with the NHW population narrowed from respectively, -46% and -65%, to -22% and -24%. The study findings align with previous observational studies, revealing lower incidence and prevalence rates of AF in US minority groups. Prevalence estimates of the adult population, when routine clinical practice is assumed, exhibit higher prevalence differences compared to settings in which monitoring for AF is assumed, particularly among Asian and Hispanic or Latino subgroups.

MeSH terms

  • Adult
  • Asian
  • Atrial Fibrillation* / diagnosis
  • Atrial Fibrillation* / epidemiology
  • Bias
  • Black or African American
  • Cohort Studies
  • Hispanic or Latino
  • Humans
  • Minority Groups
  • Randomized Controlled Trials as Topic
  • Stroke* / epidemiology
  • United States / epidemiology
  • White

Grants and funding

The authors received no specific funding for this work. LH, KH, JH, HV, YM & KS are full-time salaried employees of Janssen Research & Development, a pharmaceutical company of Johnson & Johnson. AB, CJ & AT are full-time salaried employees of Aetion, Inc. The specific roles of these authors are articulated in the ‘author contributions’ section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.